Transcriptomic analysis of Momordica charantia polysaccharide on streptozotocin-induced diabetic rats

Abstract

Polysaccharides obtained from Momordica charantia have been shown to exert a hypoglycemic effect, thereby improving glucose metabolism. However, little is known regarding the molecular mechanisms underlying this process. In recent years, RNA sequencing (RNA-seq) has rapidly emerged as a major transcriptome profiling system. Herein, RNA-seq was utilized to obtain whole transcriptomes from the livers of SD rats with type 2 diabetes (DM) and type 2 diabetic rats treated with M. charantia polysaccharides (DMCPIIa). In total, 44,752,508–52,585,920 uniquely mapped reads were obtained, covering 85.54% of the annotated transcripts and representing 12,857 mRNA transcripts. Following analytical analysis, 17 differentially expressed genes (p < 0.05, false discovery rate q < 0.05) were identified in the DMCPIIa group relative to the DM group. Gene ontology and pathway analysis demonstrated that 17 differently expressed genes were enriched in specific biological processes mainly relating to glucose metabolism and fat metabolism (p < 0.05). Furthermore, a subset of the differential genes was selected for validation via real-time quantitative reverse-transcription PCR. Collectively, the integrated analysis of differential gene expression, data obtained herein and the examination of previously reported quantitative trait loci, and genome-wide association studies has suggested that pdk4, pkl, hsd11β1, msmo1, rbp4 and fads2 may serve as promising candidates for the modulation of type 2 diabetes.